Premium
Immunohistological characterization of malignant lymphomas of the Waldeyer's ring other than the nasopharynx
Author(s) -
CHAN J.K.C.,
NG C.S.,
LO S.T.H.
Publication year - 1987
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1987.tb01896.x
Subject(s) - lymphoma , pathology , tonsil , cd20 , medicine , palatine tonsil , lymphatic system , antigen , large cell , mucosa associated lymphoid tissue , malt lymphoma , biology , adenocarcinoma , immunology , cancer
Among extranodal lymphomas, the Waldeyer's ring is the second most frequently involved site after the gastrointestinal tract. Fresh tissue from 23 consecutive cases of malignant lymphoma of the faucial tonsil, palate and base of tongue were studied histologically and with a panel of 25 monoclonal antibodies. Twenty cases were primary Waldeyer's ring lymphoma, and all were found to express B‐cell phenotype. Most cases were classified as diffuse centroblastic lymphoma, polymorphic subtype, in which there were immunoblast‐like, centrocyte‐like and/or multilobated centroblasts. All except one case expressed all three B‐cell lineage antigens CD 19, CD20 and CD22, but they showed inconsistent expression of the B‐cell antigens CD9 and CD24. Four cases lacked surface immunoglobulin. Six cases expressed interleukin‐2 receptor, suggesting that they were composed of highly activated B‐cells. Three cases represented relapse in the tonsil or tongue in patients with known malignant lymphoma in other sites; one case expressed T‐cell and two cases B‐cell phenotype (both of which also expressed interleukin‐2 receptor). The clinical features and immunohistological findings suggest that Waldeyer's ring lymphomas, other than those of the nasopharynx, share some of the characteristics of ‘mucosa‐associated lymphoid tissue’ lymphomas. In contrast, nasopharyngeal lymphomas are more related to nasal lymphomas, and are almost exclusively peripheral T‐cell neoplasms.